Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.
about
Trial Watch:: Oncolytic viruses for cancer therapyTrial Watch-Oncolytic viruses and cancer therapyImmunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapyOncolytic viruses: From bench to bedside with a focus on safety.Oncolytic immunotherapy: where are we clinically?Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumorsOncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer.Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma.Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells.Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy.Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma.Review: Oncolytic virotherapy, updates and future directions.Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administrationAddressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
P2860
Q27021951-79B7E10D-2E73-4BDE-AB55-C486504E823AQ28072347-3159E829-DFBE-4B8D-84D4-5BB3D24318FEQ30899557-240CC1C4-6F53-490C-97C8-7BD76AA76981Q34044071-E6D461AE-9580-4F36-8130-C8C7381E2518Q34405325-A08525C2-1863-4E4C-8BC5-A4A1BB39784FQ34426949-4002D874-3C4A-4EE6-8FF6-A797B9EF1A95Q35653264-870610E4-FEDC-4D03-BF4F-44C7A075D1D8Q36710972-2EC6E51D-551F-478F-BB2E-A6203315AB82Q36757131-E0ABB1CB-0AF6-45D1-88F6-C5265C1F3A35Q38534285-3F0F93EE-4AE2-4C99-B1CA-014214CD3264Q38804304-562F17BF-5425-45A5-9195-BF80B7912329Q38893420-E413C9EA-EAFA-40B5-A156-F2183DF3455EQ38914555-ACF0904A-74B1-4588-8706-F0A6D8EC871EQ39868041-20387D98-6CDE-4681-BE06-EF080123A0A1Q40674940-8FB4C73B-751D-4747-B83A-478B1BEEE31AQ47160989-0A21F6AE-1B96-4AA4-AAE0-04360AE65D04Q55510561-27AD8276-3F89-4CE3-ADE2-0312D6EEC383Q58770917-220DED25-83AB-477E-BD7A-039C43D57858Q58787920-F736FF63-D370-4FCC-9183-E7144E91A006
P2860
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@ast
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@en
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@nl
type
label
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@ast
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@en
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@nl
prefLabel
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@ast
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@en
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@nl
P2093
P50
P356
P1476
Serotype chimeric oncolytic ad ...... sarcoma in rodents and humans.
@en
P2093
Anja Kipar
Anniina Koski
Ilkka Liikanen
Lotta Vassilev
Otto Hemminki
Raita Heiskanen
Saila K Pesonen
Sari Pesonen
Simona Bramante
Suvi Parviainen
P304
P356
10.1002/IJC.28696
P50
P577
2014-01-10T00:00:00Z